Dr. Gibson reported receiving a research grant from Stealth BioTherapeutics to conduct the EMBRACE STEMI trial. He serves as a consultant to numerous pharmaceutical and medical device companies.
Conference Coverage
Novel agent fails to reduce infarct size, but may cut heart failure, protect kidneys
